In July 2025, the FDA granted priority review for TAR-200 as therapy for patients with high-risk nonmuscle invasive bladder ...
News-Medical.Net on MSN
Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback